IT1264078B1 - Uso di anticorpi anti-molecole hla classe i libere da beta-2 microglobulina per saggi di evidenziazione dell'esposizione al virus - Google Patents

Uso di anticorpi anti-molecole hla classe i libere da beta-2 microglobulina per saggi di evidenziazione dell'esposizione al virus

Info

Publication number
IT1264078B1
IT1264078B1 IT93RM000613A ITRM930613A IT1264078B1 IT 1264078 B1 IT1264078 B1 IT 1264078B1 IT 93RM000613 A IT93RM000613 A IT 93RM000613A IT RM930613 A ITRM930613 A IT RM930613A IT 1264078 B1 IT1264078 B1 IT 1264078B1
Authority
IT
Italy
Prior art keywords
hla
fhc
complex
microglobulin
analyte
Prior art date
Application number
IT93RM000613A
Other languages
English (en)
Inventor
Alberto Beretta
Original Assignee
San Romanello Centro Fond
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by San Romanello Centro Fond filed Critical San Romanello Centro Fond
Priority to IT93RM000613A priority Critical patent/IT1264078B1/it
Publication of ITRM930613A0 publication Critical patent/ITRM930613A0/it
Priority to EP94927036A priority patent/EP0717847B1/en
Priority to DE69424054T priority patent/DE69424054D1/de
Priority to AU76641/94A priority patent/AU7664194A/en
Priority to PCT/IT1994/000146 priority patent/WO1995007465A2/en
Priority to AT94927036T priority patent/ATE191975T1/de
Publication of ITRM930613A1 publication Critical patent/ITRM930613A1/it
Application granted granted Critical
Publication of IT1264078B1 publication Critical patent/IT1264078B1/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Uso di un anticorpo in grado di riconoscere sia epitopi della proteina gp160 del virus HIV che della catena pesante di HLA di classe 1, libera dalla microglobulina ?-2, (HLA FHC) per la produzione di un saggio diagnostico per la evidenziazione dell'infezione da HIV in un analito negativo per la presenza di anticorpi specifici anti-HIV, detto saggio caratterizzato dai seguenti passaggi:- incubare detto analito con un campione comprendente molecole di HLA FHC. immobilizzate su un supporto solido, in condizioni tali da permettere la formazione di un complesso analito-HLA FHC;- lavare con un tampone in condizioni non dissocianti per detto complesso;- incubare detto complesso con detto anticorpo in condizioni tali da permettere la formazione di un complesso analito HLA FHC-anticorpo;- rivelare detto complesso analito-HLA FHC-anticorpo.
IT93RM000613A 1993-09-10 1993-09-10 Uso di anticorpi anti-molecole hla classe i libere da beta-2 microglobulina per saggi di evidenziazione dell'esposizione al virus IT1264078B1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT93RM000613A IT1264078B1 (it) 1993-09-10 1993-09-10 Uso di anticorpi anti-molecole hla classe i libere da beta-2 microglobulina per saggi di evidenziazione dell'esposizione al virus
EP94927036A EP0717847B1 (en) 1993-09-10 1994-09-06 Use of antibodies against beta-2 microglobulin-free, class i hla molecules to provide hiv diagnostic tests as well as compositions having a protective action against hiv infections
DE69424054T DE69424054D1 (de) 1993-09-10 1994-09-06 Verwendung von antikörpern gegen beta-2-mikroglobulin-freie klasse-i-hla-molekülen zum erhalt eines diagnostischen hiv-tests und zusammensetzungen mit schutzwirkung gegen hiv-infektionen
AU76641/94A AU7664194A (en) 1993-09-10 1994-09-06 Use of antibodies against beta -2 microglobulin-free, class i hla molecules to provide hiv diagnostic tests as well as compositions having a protective action against hiv infections
PCT/IT1994/000146 WO1995007465A2 (en) 1993-09-10 1994-09-06 USE OF ANTIBODIES AGAINST β-2 MICROGLOBULIN-FREE, CLASS I HLA MOLECULES TO PROVIDE HIV DIAGNOSTIC TESTS AS WELL AS COMPOSITIONS HAVING A PROTECTIVE ACTION AGAINST HIV INFECTIONS
AT94927036T ATE191975T1 (de) 1993-09-10 1994-09-06 Verwendung von antikörpern gegen beta-2- mikroglobulin-freie klasse-i-hla-molekülen zum erhalt eines diagnostischen hiv-tests und zusammensetzungen mit schutzwirkung gegen hiv- infektionen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93RM000613A IT1264078B1 (it) 1993-09-10 1993-09-10 Uso di anticorpi anti-molecole hla classe i libere da beta-2 microglobulina per saggi di evidenziazione dell'esposizione al virus

Publications (3)

Publication Number Publication Date
ITRM930613A0 ITRM930613A0 (it) 1993-09-10
ITRM930613A1 ITRM930613A1 (it) 1995-03-10
IT1264078B1 true IT1264078B1 (it) 1996-09-10

Family

ID=11401948

Family Applications (1)

Application Number Title Priority Date Filing Date
IT93RM000613A IT1264078B1 (it) 1993-09-10 1993-09-10 Uso di anticorpi anti-molecole hla classe i libere da beta-2 microglobulina per saggi di evidenziazione dell'esposizione al virus

Country Status (6)

Country Link
EP (1) EP0717847B1 (it)
AT (1) ATE191975T1 (it)
AU (1) AU7664194A (it)
DE (1) DE69424054D1 (it)
IT (1) IT1264078B1 (it)
WO (1) WO1995007465A2 (it)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254360B (it) * 1992-05-11 1995-09-14 San Romanello Centro Fond Epitopi immunologicamente omologhi di hla e proteine del virus hiv.

Also Published As

Publication number Publication date
DE69424054D1 (de) 2000-05-25
ITRM930613A1 (it) 1995-03-10
ATE191975T1 (de) 2000-05-15
EP0717847A1 (en) 1996-06-26
AU7664194A (en) 1995-03-27
WO1995007465A2 (en) 1995-03-16
WO1995007465A3 (en) 1995-04-13
ITRM930613A0 (it) 1993-09-10
EP0717847B1 (en) 2000-04-19

Similar Documents

Publication Publication Date Title
KR860700046A (ko) HTLV-Ⅲ 단백질의 분리, AIDS와 pre-AIDS 증상환자 혈청중의 HTLV-Ⅲ에 대한 항체의 혈청학적 검출 및 HTLV-Ⅲ과 이것의 단백질을 사용하는 면역 분석에 의한 HTLV-Ⅲ감염의 검사
BRPI0210598B8 (pt) processos para a produção de um complexo solúvel que compreende uma proteína amiloidogênica alvo e uma chaperona peptidil-prolil-isomerase, para a produção de um complexo de glicoproteína retroviral de superfície-chaperona solúvel, e para detectar pelo menos um anticorpo para uma glicoproteína retroviral de superfície em uma amostra, bem como complexo solúvel, e composição
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
SE9103183L (sv) Virus-antikroppskomplex
PT649537E (pt) Imunoanalises para anticorpos anti-vhc utilizando antigenios com epitopos conformacionais
CA2224003A1 (en) Fluorescence resonance energy transfer screening assay for the identification of hiv-1 envelope glycoprotein-medicated cell
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
Davey et al. Laboratory Methods in the Diagnosis and Prognostic Staging of infection with Human Immunodificiency Virus Type 1
DE3584035D1 (de) Nachweis von menschlichem cytomegalovirus-spezifischem igm.
FI935217A (fi) Basisk dissocieringsanalys
ES2187947T3 (es) Procedimiento para la determinacion simultanea de antigenos de hiv y anticuerpos de hiv.
DK0457804T3 (da) M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop
DE68921360D1 (de) Monoklonale Antikörper von Mäusen gegen das gp41 Protein von menschlichem Immunmangelsyndrom-Virus.
SE9000595D0 (sv) New peptides, diagnostic antigens and an immunoassay method
ES2159291T3 (es) Metodo y analisis de htlv-i/htlv-ii.
KR880014376A (ko) Hiv 특이 항원 영역의 모노클로날 항체 및 그 용법
IT1264078B1 (it) Uso di anticorpi anti-molecole hla classe i libere da beta-2 microglobulina per saggi di evidenziazione dell'esposizione al virus
SE8302329D0 (sv) T-cell-leukemiantigener, sett for framstellning derav och for analys av antikroppar
KR920701243A (ko) T-임파 추향성 레트로 비루스 모노크로날항체
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
RU96110599A (ru) Способ диагностики лепры
RU2002115475A (ru) Иммуноферментный способ определения растворимой формы HLA-DR антигенов в сыворотке крови человека
Portetelle et al. Competition enzyme-linked immunosorbent assay(ELISA) for the diagnosis of bovine leukemia virus infection.
WO1996041189B1 (en) Test of hiv-specific t lymphocyte function that detects exposure to hiv antigens and possibly early hiv infection
BR9102727A (pt) Processo para a preparacao de um anticorpo monoclonal, anticorpos monoclonais, linha de celulas, processo para sua preparacao, processo para a determinacao imunologica de herbicidas de sulfonilureia, agente para determinacao imunologica, componente de copulacao e processo para a preparacao de um componente

Legal Events

Date Code Title Description
0001 Granted